APT End Period Cash Flow from 2010 to 2024

688617 Stock   362.62  10.47  2.97%   
APT Medical's End Period Cash Flow is increasing over the years with slightly volatile fluctuation. Overall, End Period Cash Flow is expected to go to about 1.3 B this year. From 2010 to 2024 APT Medical End Period Cash Flow quarterly data regression line had arithmetic mean of  272,993,109 and r-squared of  0.45. View All Fundamentals
 
End Period Cash Flow  
First Reported
2019-09-30
Previous Quarter
654.2 M
Current Value
721 M
Quarterly Volatility
311.2 M
 
Covid
Check APT Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among APT Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 76.1 M, Interest Expense of 3.9 M or Selling General Administrative of 346.8 M, as well as many indicators such as . APT financial statements analysis is a perfect complement when working with APT Medical Valuation or Volatility modules.
  
This module can also supplement various APT Medical Technical models . Check out the analysis of APT Medical Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in APT Stock

APT Medical financial ratios help investors to determine whether APT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in APT with respect to the benefits of owning APT Medical security.